These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8241675

  • 1. Severe hyperlipoproteinemia in congenital nephrotic syndrome of the Finnish type: effect of dialysis and kidney transplantation.
    Salo MK, Jaakkola O, Solakivi T, Ylä-Herttuala S.
    Acta Paediatr; 1993 Sep; 82(9):768-72. PubMed ID: 8241675
    [Abstract] [Full Text] [Related]

  • 2. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
    Antikainen M, Holmberg C, Taskinen MR.
    Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
    [Abstract] [Full Text] [Related]

  • 3. Protein and lipid metabolism in nephrotic infants on peritoneal dialysis after nephrectomy.
    Antikainen M.
    Pediatr Nephrol; 1993 Aug; 7(4):428-33. PubMed ID: 8398654
    [Abstract] [Full Text] [Related]

  • 4. Treatment of nephrotic hyperlipoproteinemia with gemfibrozil.
    Groggel GC, Cheung AK, Ellis-Benigni K, Wilson DE.
    Kidney Int; 1989 Aug; 36(2):266-71. PubMed ID: 2779095
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO, Alaupovic P.
    Am J Nephrol; 1990 Aug; 10 Suppl 1():69-75. PubMed ID: 2256478
    [Abstract] [Full Text] [Related]

  • 6. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R, Riesen W.
    Schweiz Med Wochenschr; 1982 Sep 25; 112(39):1335-40. PubMed ID: 6755693
    [Abstract] [Full Text] [Related]

  • 7. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
    Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inoue T, Morii H.
    Atherosclerosis; 1997 Jun 25; 131(2):229-36. PubMed ID: 9199276
    [Abstract] [Full Text] [Related]

  • 8. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP, Soltys G, Mangel R, Kwiterovitch P, Sniderman AD.
    Transplant Proc; 1987 Feb 25; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract] [Full Text] [Related]

  • 9. Hyperlipoproteinemia in adults with renal disease.
    Anderson CF.
    Mayo Clin Proc; 1993 Apr 25; 68(4):358-62. PubMed ID: 8455394
    [Abstract] [Full Text] [Related]

  • 10. Renal transplantation in small children with congenital nephrotic syndrome of the Finnish type.
    Holmberg C, Jalanko H, Koskimies O, Leijala M, Salmela K, Eklund B, Ahonen J.
    Transplant Proc; 1991 Feb 25; 23(1 Pt 2):1378-9. PubMed ID: 1989242
    [No Abstract] [Full Text] [Related]

  • 11. Pattern of hyperlipoproteinemia in human nephrotic syndrome: influence of renal failure and diabetes mellitus.
    Joven J, Villabona C, Vilella E.
    Nephron; 1993 Feb 25; 64(4):565-9. PubMed ID: 8366982
    [Abstract] [Full Text] [Related]

  • 12. Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study.
    Jin K, Park BS, Kim YW, Vaziri ND.
    Am J Kidney Dis; 2014 Apr 25; 63(4):584-9. PubMed ID: 24315769
    [Abstract] [Full Text] [Related]

  • 13. Ability of non-high-density lipoprotein cholesterol and calculated intermediate-density lipoprotein to identify nontraditional lipoprotein subclass risk factors in dialysis patients.
    Belani SS, Goldberg AC, Coyne DW.
    Am J Kidney Dis; 2004 Feb 25; 43(2):320-9. PubMed ID: 14750098
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA, Gaber AO, Amiri HS, Wang X, Elmer DS, Winsett RP, Hathaway DK, Hughes SM, Ghawji M.
    Metabolism; 1994 Mar 25; 43(3):333-47. PubMed ID: 8139482
    [Abstract] [Full Text] [Related]

  • 15. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C, Lisch HJ, Drexel H, Braunsteiner H.
    Schweiz Med Wochenschr; 1983 Jun 25; 113(25):909-13. PubMed ID: 6612272
    [Abstract] [Full Text] [Related]

  • 16. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 Jun 25; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J, Bar-On H, Shafrir E.
    Isr J Med Sci; 1981 Nov 25; 17(11):1001-8. PubMed ID: 7319786
    [Abstract] [Full Text] [Related]

  • 18. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M, Berg A, Baumstark MW, König D, Huonker M, Keul Joseph.
    Atherosclerosis; 1999 Mar 25; 143(1):185-92. PubMed ID: 10208494
    [Abstract] [Full Text] [Related]

  • 19. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND.
    Kidney Int; 2016 Jul 25; 90(1):41-52. PubMed ID: 27165836
    [Abstract] [Full Text] [Related]

  • 20. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug 25; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.